rss
Br J Ophthalmol 2000;84:983-986 doi:10.1136/bjo.84.9.983
  • Original Article
    • Clinical science

Recombinant tissue plasminogen activator following paediatric cataract surgery

  1. J S Mehta,
  2. G G W Adams
  1. Strabismus and Paediatric Service, Moorfields Eye Hospital, London
  1. Dr J S Mehtajodmehta{at}hotmail.com
  • Accepted 26 April 2000

Abstract

BACKGROUND The use of recombinant tissue plasminogen activator (r-TPA) has been advocated in the treatment of postsurgical fibrinous membrane formation following cataract surgery in adults. Its use in paediatric cases is not well documented.

METHOD A retrospective review of paediatric cataract extractions performed at Moorfields Eye Hospital between 1 January 1997 and 4 April 1999 was carried out.

RESULTS Cataract extractions were performed in 37 patients, 22 in males 15 in females. Four (9.2%) underwent intracameral injection of 25 μg r-TPA. They were all females of Afro-Caribbean origin. The time to injection varied from 4–14 days, mean 7.2 days. Complete resolution of the fibrinous membrane was seen in all cases. There were no complications by the 3 month follow up.

CONCLUSION r-TPA may be used safely and effectively at a dose of 25 μg for the treatment of severe fibrinous membranes following paediatric cataract extraction. It aided the visual recovery of the children and also allowed a reduced regimen of topical steroid therapy to be used postoperatively.

Footnotes

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Responses

    1. Submit a response
    2. No responses published

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.